Skip to search formSkip to main contentSkip to account menu

robalzotan

Known as: 3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate monohydrate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Benzopyrans

Narrower (1)

NAD 299

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Central serotonergic control of cardiovascular reflexes.
Central serotonergic neurones control reflex parasympathetic outflow to the heart, airways and bladder in a number of species… 
Review
2000
Review
2000
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
2000
2000
Robalzotan AstraZeneca.
AstraZeneca (formerly Astra) is developing robalzotan, a 5-HT1A antagonist, for the potential treatment of depression and anxiety… 
1998
1998
Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)